Dr. Agarwal's Health Care IPO
IPO Details Status: Closed
Docs DRHP View Subscription :1.48x
Bidding Dates 29 Jan '25 - 31 Jan '25 | Minimum Investment ₹13,370 / 1 Lot (35Shares) | Price Range ₹382- ₹402 |
Listing Gain ₹48 | Fresh Issue Offer for Sale 300.00 Cr 2727.26 Cr | Issue Size ₹3027.26 Cr |
Face Value ₹ 01 | GMP 40 _10% | Listing AT NSE,BSE |
IPO Timeline
IPO Opening Date Jan 29, 2025 | IPO Closing Date Jan 31, 2025 | Basis of Allotment Feb 03, 2025 | Initiation of Refunds Feb 04, 2025 | IPO Listing Date Feb 05, 2025 |
Dr. Agarwal's Health Care Subscription Details
Date | QIB | NII | Retail | EMP | Others | Total |
| 28-01-2025 | 0 | 0.04 | 0.1 | 0.07 | 0.06 | 0.07 |
| 29-01-2025 | 0.95 | 0.10 | 0.22 | 0.16 | 0.36 | 0.39 |
| 30-01-2025 | 4.41 | 0.39 | 0.40 | 0.26 | 0.48 | 1.48 |
Dr. Agarwal's Health Care IPO Reservation
Investor Category | Shares Offered |
QIB Shares | 50% |
Retail Shares | 35% |
NII (HNI) Shares | 15% |
Dr. Agarwal's Health Care Financial Information
Period Ended | 30-09-2024 | 31-03-2024 | 31-03-2023 | 31-03-2022 |
| Assets | 3393.41 | 2752.82 | 1825.17 | 1026.13 |
| Revenue | 837.94 | 1376.45 | 1031.39 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
About Dr. Agarwal's Health Care
Dr. Agarwal's Health Care Limited is an eye care services provider that provides a wide range of eye treatments, such as consultations, pharmaceutical goods, and cataract and refractive procedures. Because of its "hub-and-spoke" business strategy, the organisation may expand geographically and use resources more effectively. The spoke denotes primary and secondary facilities, while the hub is the tertiary facility. The BSE-listed subsidiary, Dr. Agarwal's Eye Hospital, was founded in 1994 and is owned by Dr. Agarwal's Health Care.
The corporation has 193 facilities in 14 states and 4 union territories in India as of September 30, 2024, which includes 165 spokes and 28 hubs. It operates sixteen sites in nine African nations. The business had a 25% market share in India's organized eye care service chain in FY24.
737 physicians work for the company across all of its locations. In FY24, the business conducted 220,523 procedures and served 21 lakh patients. In FY24, the hospital had 64.20% of its total revenue from surgeries, 12.83% from the sale of optical products, contact lenses, and accessories, and the remaining portion from the sale of pharmaceuticals connected to eye care
Since FY20, the company has added facilities in Punjab, Tamil Nadu, and Mumbai, totaling more than 60. The organization runs three Centres of Excellence (COEs) that provide cutting-edge surgical skills and educational opportunities.
Dr. Agarwal's Health Care IPO Objectives
The company's proposed use of the issue's net proceeds is as follows:
Repayment and prepayment of borrowings: The business will utilize ₹195.00 crores to fully or partially repay and prepay some of its borrowings.
General Corporate Purposes and Inorganic Acquisition: A portion of the issue's gross proceeds, up to 25%, will be allocated to general corporate requirements or unspecified inorganic acquisitions.
Dr. Agarwal's Health Care IPO: Strengths
In FY2024, Dr. Agarwal's Health Care Limited, an eye care chain, had a 25% market share and 1.7 times the sales of the second-largest competitor. With 193 sites in India and 16 in nine African nations, it guarantees a broad patient base.
Established in 1994, Dr. Agarwal's Eye Hospital is a subsidiary of Dr. Agarwal's Health Care, which also manages the operations of the listed company. The company owns 71.9% of the hospital.
Complete eye care services, including surgery, non-surgical care, consultations, diagnostics, and pharmaceutical and optical goods all under one roof.
With the help of integrated pharmacies, optical counters, and sophisticated surgical capabilities, standardized operating procedures across facilities guarantee reliable, superior patient experiences.
Dr. Agarwal's Health Care IPO: Risks
Reliance on retainership contracts with physicians may have an impact on patient volumes, service quality, and financial outcomes in the event of terminations or retention issues.
The business works in a regulated field, and breaking safety, health, environmental, or other rules could lead to fines, delays, and other negative effects.
The company's 120 out of 193 facilities in Tamil Nadu, Maharashtra, and Karnataka account for 42.19% of its revenue in the first half of FY25. Negative changes in these states may have an adverse effect on the financial and business performance of companies.
Complaints against the business have included arbitration and disagreements with physicians on non-compete clauses, which may result in penalties, increased compliance expenses, and disruptions to business operations.
How To Apply for Dr. Agarwal's Health Care IPO Online?
Click and Login to Your Angel One Account : Open the Angel One app or website and log in with your credentials.
Locate the IPO Section: Navigate to the 'IPO' section on the platform.
Select IPO: Find and select the Laxmi Dental IPO from the list of open IPOs.
Enter the Lot Size: Specify the number of lots you want to bid for.
Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
Important Link
